Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in infants with congenital heart disease, left-to-right shunt, and severe pulmonary hypertension undergoing cardiac surgery
IRCT2016081619470N40Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in Cardiovascular Malformation (CVM) and pulmonary hypertension (PH), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Pulmonary hypertensive crisis, Arrhythmias and 1 more. Started Apr 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)pulmonary hypertension (PH)
Beyond the preview
Go deeper on IRCT2016081619470N40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016081619470N40.